| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1013425421 |
| P356 | DOI | 10.1208/S12248-015-9772-2 |
| P932 | PMC publication ID | 4477000 |
| P698 | PubMed publication ID | 25921939 |
| P5875 | ResearchGate publication ID | 275656153 |
| P50 | author | Meghna Talekar | Q56942818 |
| P2093 | author name string | Mansoor Amiji | |
| Thanh-Huyen Tran | |||
| P2860 | cites work | A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation | Q84117546 |
| Exploring the full spectrum of macrophage activation | Q24653754 | ||
| Anti-inflammatory therapy in chronic disease: challenges and opportunities | Q26860162 | ||
| Development of macromolecular prodrug for rheumatoid arthritis | Q27693332 | ||
| Alternative activation of macrophages | Q27860939 | ||
| Angiogenesis in cancer and other diseases | Q27861015 | ||
| Cancer statistics, 2014 | Q27861018 | ||
| Hypoxia inducible factor-1alpha as a cancer drug target | Q28261521 | ||
| Therapeutic efficacy and safety of paclitaxel/lonidamine loaded EGFR-targeted nanoparticles for the treatment of multi-drug resistant cancer | Q28476850 | ||
| Monocyte and macrophage heterogeneity | Q29547438 | ||
| Targeting hypoxia in cancer therapy | Q29615491 | ||
| Mechanisms of cancer drug resistance | Q29615849 | ||
| Nonresolving inflammation | Q29616352 | ||
| Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review | Q29617388 | ||
| A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis | Q29619201 | ||
| The impact of O2 availability on human cancer | Q29619884 | ||
| Accelerated discovery of synthetic transfection vectors: parallel synthesis and screening of a degradable polymer library. | Q31002502 | ||
| Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells | Q31660362 | ||
| Beta-amino ester polymers facilitate in vivo DNA transfection and adjuvant plasmid DNA immunization | Q33217360 | ||
| Dendrimer-modified magnetic nanoparticles enhance efficiency of gene delivery system | Q33297462 | ||
| Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer | Q33303505 | ||
| The role of mechanical forces in tumor growth and therapy | Q33942378 | ||
| Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression | Q34136997 | ||
| Mad2 checkpoint gene silencing using epidermal growth factor receptor-targeted chitosan nanoparticles in non-small cell lung cancer model | Q34293616 | ||
| Hydrodynamic delivery of chitosan-folate-DNA nanoparticles in rats with adjuvant-induced arthritis | Q34496985 | ||
| MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-α-PU.1 pathway. | Q34606028 | ||
| RNAi therapeutics: principles, prospects and challenges | Q34621268 | ||
| Regulation of chemokine expression by antiinflammatory cytokines. | Q34644481 | ||
| Evaluations of combination MDR-1 gene silencing and paclitaxel administration in biodegradable polymeric nanoparticle formulations to overcome multidrug resistance in cancer cells. | Q34794648 | ||
| Effects of interleukin-4 or interleukin-10 gene therapy on trinitrobenzenesulfonic acid-induced murine colitis | Q35062006 | ||
| IL-4/IL-13-dependent and independent expression of miR-124 and its contribution to M2 phenotype of monocytic cells in normal conditions and during allergic inflammation | Q35072554 | ||
| Layer-by-layer nanoparticles with a pH-sheddable layer for in vivo targeting of tumor hypoxia | Q35074580 | ||
| Pharmacokinetics and biodistribution of lonidamine/paclitaxel loaded, EGFR-targeted nanoparticles in an orthotopic animal model of multi-drug resistant breast cancer | Q35106014 | ||
| Gene transfer approaches for the treatment of inflammatory bowel disease | Q35122162 | ||
| Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies. | Q35202899 | ||
| 'Click' synthesis of dextran macrostructures for combinatorial-designed self-assembled nanoparticles encapsulating diverse anticancer therapeutics | Q35380806 | ||
| Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease | Q35599842 | ||
| RNA interference-mediated silencing of the polo-like kinase 1 gene enhances chemosensitivity to gemcitabine in pancreatic adenocarcinoma cells | Q35886662 | ||
| The updated biology of hypoxia-inducible factor | Q36001994 | ||
| Therapeutic gene delivery and transfection in human pancreatic cancer cells using epidermal growth factor receptor-targeted gelatin nanoparticles | Q36104491 | ||
| Signal transduction for chemotaxis and haptotaxis by matrix molecules in tumor cells | Q36222822 | ||
| Drug-target residence time and its implications for lead optimization | Q36556505 | ||
| Lipid-functionalized dextran nanosystems to overcome multidrug resistance in cancer: a pilot study | Q36585890 | ||
| Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA. | Q36649938 | ||
| RNAi therapeutics: a potential new class of pharmaceutical drugs | Q36654918 | ||
| Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors | Q36795709 | ||
| Biodistribution and pharmacokinetics of EGFR-targeted thiolated gelatin nanoparticles following systemic administration in pancreatic tumor-bearing mice | Q36836865 | ||
| The role of hypoxia-inducible factors in tumorigenesis. | Q37079708 | ||
| A review of stimuli-responsive nanocarriers for drug and gene delivery | Q37080358 | ||
| Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibi | Q37089685 | ||
| Anti-inflammatory Agents: Present and Future | Q37118156 | ||
| RNAi Therapeutic Platforms for Lung Diseases | Q37277373 | ||
| Gene therapy approaches to enhance bioreductive drug treatment | Q37280249 | ||
| miR-125a-5p regulates differential activation of macrophages and inflammation. | Q37368700 | ||
| In vivo biodistribution of siRNA and cisplatin administered using CD44-targeted hyaluronic acid nanoparticles | Q37381483 | ||
| Shedding light on tumors using nanoparticles | Q37389451 | ||
| Targeting IL-6 in the treatment of inflammatory and autoimmune diseases | Q37588720 | ||
| Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism | Q37588989 | ||
| In vivo silencing of the transcription factor IRF5 reprograms the macrophage phenotype and improves infarct healing. | Q37710952 | ||
| Targeting of nanoparticles in cancer: drug delivery and diagnostics | Q37942288 | ||
| Transcriptional regulation of macrophage polarization: enabling diversity with identity | Q37949245 | ||
| Pharmacological strategies to resolve acute inflammation | Q38098326 | ||
| Emerging cell and cytokine targets in rheumatoid arthritis | Q38161794 | ||
| Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies. | Q38177110 | ||
| Hypoxia-responsive polymeric nanoparticles for tumor-targeted drug delivery | Q39051930 | ||
| Nanoparticles of 2-deoxy-D-glucose functionalized poly(ethylene glycol)-co-poly(trimethylene carbonate) for dual-targeted drug delivery in glioma treatment | Q39078576 | ||
| Cytokines in inflammatory bowel disease | Q39206254 | ||
| Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth | Q39290507 | ||
| Phosphatidylinositol 3-kinase inhibitor (PIK75) containing surface functionalized nanoemulsion for enhanced drug delivery, cytotoxicity and pro-apoptotic activity in ovarian cancer cells | Q39338877 | ||
| Multi-compartmental nanoparticles-in-emulsion formulation for macrophage-specific anti-inflammatory gene delivery | Q39405505 | ||
| Transferrin mediated solid lipid nanoparticles containing curcumin: enhanced in vitro anticancer activity by induction of apoptosis | Q39676512 | ||
| A drug-loaded aptamer-gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer | Q39692824 | ||
| Silencing of pkm2 increases the efficacy of docetaxel in human lung cancer xenografts in mice | Q39699461 | ||
| Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model | Q39723159 | ||
| Efficient suppression of murine arthritis by combined anticytokine small interfering RNA lipoplexes | Q39955543 | ||
| Acid-mediated tumor invasion: a multidisciplinary study | Q40278705 | ||
| Effects of treatment with small interfering RNA on joint inflammation in mice with collagen-induced arthritis | Q40437124 | ||
| Silencing of polo-like kinase (Plk) 1 via siRNA causes induction of apoptosis and impairment of mitosis machinery in human prostate cancer cells: implications for the treatment of prostate cancer. | Q40468352 | ||
| Magnetite nanoparticle-loaded anti-HER2 immunoliposomes for combination of antibody therapy with hyperthermia | Q40529070 | ||
| Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation | Q40832683 | ||
| Interendothelial junctions: structure, signalling and functional roles. | Q41612546 | ||
| MicroRNA let-7c regulates macrophage polarization. | Q41855099 | ||
| Ustekinumab induction and maintenance therapy in refractory Crohn's disease | Q42514321 | ||
| Synthesis of poly(beta-amino ester)s optimized for highly effective gene delivery | Q42795918 | ||
| Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease | Q44477953 | ||
| Plasmid encoding interleukin-4 in the amelioration of murine collagen-induced arthritis | Q45873758 | ||
| Oral IL-10 gene delivery in a microsphere-based formulation for local transfection and therapeutic efficacy in inflammatory bowel disease | Q45876830 | ||
| Mannose-based molecular patterns on stealth microspheres for receptor-specific targeting of human antigen-presenting cells | Q46374200 | ||
| Synthesis of a novel galactosylated lipid and its application to the hepatocyte-selective targeting of liposomal doxorubicin | Q46754852 | ||
| Metallothionein is up-regulated under hypoxia and promotes the survival of human prostate cancer cells | Q46968197 | ||
| CCL17 and IL-10 as effectors that enable alternatively activated macrophages to inhibit the generation of classically activated macrophages. | Q51720779 | ||
| Multifunctional polymeric nanoparticles for oral delivery of TNF-α siRNA to macrophages. | Q51835905 | ||
| Hyaluronate-gold nanoparticle/tocilizumab complex for the treatment of rheumatoid arthritis. | Q53574722 | ||
| Stromal reaction in cancer tissue: pathophysiologic significance of the expression of matrix-degrading enzymes in relation to matrix turnover and immune/inflammatory reactions | Q74555223 | ||
| Silencing of polo-like kinase (Plk) 1 via siRNA causes inhibition of growth and induction of apoptosis in human esophageal cancer cells | Q81803693 | ||
| Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences | Q81880357 | ||
| Tuftsin-modified alginate nanoparticles as a noncondensing macrophage-targeted DNA delivery system | Q83560744 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nanotechnology | Q11468 |
| P304 | page(s) | 813-827 | |
| P577 | publication date | 2015-04-29 | |
| P1433 | published in | The AAPS Journal | Q10695361 |
| P1476 | title | Translational Nano-Medicines: Targeted Therapeutic Delivery for Cancer and Inflammatory Diseases | |
| P478 | volume | 17 |
| Q90675224 | Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization |
| Q48054718 | Dynamics of rebounding Bacillus subtilis spores determined using image-charge detection. |
| Q59800507 | Editorial: Advances and Challenges in Nanomedicine |
| Q90109892 | Monocyte metabolic reprogramming promotes pro-inflammatory activity and Staphylococcus aureus biofilm clearance |
| Q28384480 | Nanoparticles and direct immunosuppression |
| Q30368171 | Novel delivery approaches for cancer therapeutics. |
| Q89260062 | Remotely Triggered Nano-Theranostics For Cancer Applications |
| Q37690819 | The Current State of Nanoparticle-Induced Macrophage Polarization and Reprogramming Research |
| Q99551899 | Tumor-associated macrophages: Role in the pathological process of tumorigenesis and prospective therapeutic use (Review) |
Search more.